Swing Therapeutics

San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of novel prescription digital therapeutics designed to empower people to live joyful and vibrant lives. Swing Therapeutics is based in San Francisco, CA and was founded in 2019. It was valued at $24.3 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $31.4 million across 4 recorded rounds; the latest was a $3.3 million seed round in Aug 2025.

PMV mark · valuation
$24.3M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$31.4M
Last round
Seed Round
Aug 2025
What is Swing Therapeutics worth?
$24.3MPrivateMarketView mark · Oct 2026

Valued at $24.3M at its later-stage round, Aug 2025. Nothing has traded since.

Free account
More of Swing Therapeutics with a free account
  • ·Watch Swing Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Swing Therapeutics funding history

4 rounds
DateRoundRaisedPost-money
Aug 2025Seed Round$3.3M▮
May 2025Early Stage VC$11.4M▮
Jan 2022Early Stage VC$10.3M▮
Aug 2019Early Stage VC$9.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Swing Therapeutics valuation

Swing Therapeutics was valued at $24.3 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Swing Therapeutics raised?

Swing Therapeutics has raised $31.4 million across 4 recorded rounds since 2019. The largest was a $9.2 million early-stage round in Aug 2019; the most recent was a $3.3 million seed round in Aug 2025.

Swing Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently in Sep 2025 ($3.3 million sold to 1 investor).

How Swing Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Swing Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Swing Therapeutics

What is Swing Therapeutics worth?
Swing Therapeutics is valued at $24.3M as of Oct 2026. Valued at $24.3M at its later-stage round, Aug 2025. Nothing has traded since.
How much has Swing Therapeutics raised?
Swing Therapeutics has raised $31.4M in total funding across 4 recorded rounds.
When did Swing Therapeutics last raise?
Swing Therapeutics last raised in Aug 2025 (Seed Round), raising $3.3M.